Latest News for: gbm
Edit
SICO Capital Named ‘Equity Fund of the Year’ at the 2026 GBM Middle East Awards (SICO Capital CJSC)
Public Technologies 07 Jul 2026
Edit
ADIB wins two awards at GBM Middle East Awards 2026
The Gulf Time 29 Jun 2026
Abu Dhabi Islamic Bank (ADIB) has won two awards at the Global Banking & Markets (GBM) Middle East Awards 2026, receiving the Rising Star Sukuk House of the Year and Islamic Project Finance House of the Year awards.
Edit
Dentons advises on six award-winning deals at GBM Middle East 2026 (Dentons US LLP)
Public Technologies 25 Jun 2026
) June 25, 2026. Dubai-Six deals on which Dentons advised have been recognised at the GBM Middle East 2026 Awards, winning six prestigious accolades across the banking, finance and capital markets sectors ... Dentons advised the lenders ... About Dentons.
Edit
Knoa Pharma and GCAR Announce First Newly Diagnosed Glioblastoma Patient Randomized in Phase 2/3 GBM AGILE Evaluation of Tinostamustine and First Recurrent Patient Dosed
PR Newswire 24 Jun 2026
Glioblastoma (GBM) is an aggressive brain cancer that is challenging to treat and currently has no cure.1 ... Prior clinical research has evaluated tinostamustine in patients with MGMT promoter-unmethylated glioblastoma (uMGMT GBM).
Edit
The Bay City Tribune
06 Jun 2026
Diakonos Oncology Shares Updated DOC1021 GBM Survival Data and Unveils Melanoma Clinical Study at ASCO 2026
Updated DOC1021 data in newly diagnosed glioblastoma show 90% ...
Edit
Accreditation of Cambodia CB Announced at 68th GBM in New Delhi (APO - Asian Productivity Organization)
Public Technologies 28 May 2026
) APO Secretary-General Dr ... [...]. This is an abstract of the document ... Attachments Original document Permalink. Disclaimer ... (noodl. 132068041) .
Edit
68th GBM in India Strategizes APO Vision 2030 Implementation for Productivity Transformation and Enhanced Regional Cooperation
Nasdaq Globe Newswire 26 May 2026
APO member economies advance Vision 2030 implementation and regional productivity cooperation at the 68th GBM in India ... .
Edit
Williston Observer
20 May 2026
Myosin Therapeutics Initiates Phase 1/2 STAR-GBM Trial of MT-125 Targeting Non-muscle Myosin II in Newly ...
Edit
BioLineRx and Hemispherian Announce New GLIX1 Data Demonstrating Potent Anti-Tumor Effect in Glioblastoma (GBM) Across Multiple In-Vivo Studies, Including a Temozolomide (TMZ)-Resistant Model with Patient-Derived Xenografts (BioLineRX Ltd)
Public Technologies 19 May 2026
). The text version of this document is not available ... Disclaimer. BioLineRX Ltd.
Edit
Myosin Therapeutics Initiates Phase 1/2 STAR-GBM Trial of MT-125 Targeting Non-muscle Myosin II in Newly Diagnosed Glioblastoma
PR Newswire 19 May 2026
JUPITER, Fla., May 19, 2026 /PRNewswire/ -- Myosin Therapeutics, a clinical stage biotechnology company developing innovative therapies for oncology, today announced that the first patient has been dosed in its Phase 1/2 STAR-GBM study.
Edit
BioLineRx and Hemispherian Announce New GLIX1 Data Demonstrating Potent Anti-Tumor Effect in Glioblastoma (GBM) Across Multiple In-Vivo Studies, Including a Temozolomide (TMZ)-Resistant Model with Patient-Derived Xenografts
PR Newswire 19 May 2026
Edit
Results highlight GLIX1’s potential to address the high unmet need for patients with GBM (Form 6-K) (BioLineRX Ltd)
Public Technologies 19 May 2026
Edit
BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) (BioLineRX Ltd)
Public Technologies 28 Apr 2026
). The text version of this document is not available ... Disclaimer. BioLineRX Ltd.
Edit
BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) (Form 6-K) (BioLineRX Ltd)
Public Technologies 28 Apr 2026
the Treatment of Glioblastoma (GBM) ... GBM remains one of the most aggressive and treatment-resistant cancers, and there is an urgent need for breakthrough innovation and more effective treatment options.
- 1
- 2
- Next page »